Gene · 8742
Papers2,943
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,943
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy. | Cell Death Dis | 2026 | 41633975 | PubTator, text mining | PubMed |
| Iparomlimab and tuvonralimab (QL1706) combined definitive chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma (QL1706-IIT-02): a single arm, phase 2 trial. | EClinicalMedicine | 2026 | 41623855 | PubTator, text mining | PubMed |
| Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics. | J Biol Chem | 2026 | 41621483 | PubTator, text mining | PubMed |
| Macrophage AMPK activated by oxidative stress drives profibrotic crosstalk with tubular cells to accelerate renal fibrosis after ischemic and reperfusion injury. | Redox Biol | 2026 | 41621245 | PubTator, text mining | PubMed |
| TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapy. | Cell Mol Immunol | 2026 | 41611908 | PubTator, text mining | PubMed |
| Partial-EMT in oral squamous cell carcinoma: molecular circuitry and clinical translation. | Int J Oral Sci | 2026 | 41611665 | PubTator, text mining | PubMed |
| In Vitro Analysis of TWEAK/Fn14 Axis in the Blood-Brain Barrier Models during Oxygen-Glucose Deprivation and Reoxygenation. | Mol Neurobiol | 2026 | 41606398 | PubTator, text mining | PubMed |
| Deciphering RNA and protein expression discordance identifies TOP2A as a prognostic biomarker and potential therapeutic target in lung adenocarcinoma. | Discov Oncol | 2026 | 41604018 | PubTator, text mining | PubMed |
| Comment on 'Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) is associated with inflammation and disease severity in pemphigus'. | Br J Dermatol | 2026 | 41593009 | PubTator, text mining | PubMed |
| Immune Unresponsiveness to Cardiopulmonary Bypass Is Associated With Unfavorable Outcome in Infants Requiring Cardiac Surgery. | JACC Basic Transl Sci | 2026 | 41589780 | PubTator, text mining | PubMed |
| The TWEAK/FN14 axis influences the phenotype of cardiac fibroblasts during pathological cardiac remodeling through the regulation of EGR1. | Eur J Pharmacol | 2026 | 41580010 | PubTator, text mining | PubMed |
| Single-cell landscape of immune cells in multiple autoimmune diseases. | iScience | 2026 | 41561386 | PubTator, text mining | PubMed |
| Association of programmed cell death with atrial fibrillation risk: A multi-omics Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41560081 | PubTator, text mining | PubMed |
| Mechanistic and systemic perspectives on tumour necrosis factor-like weak inducer of apoptosis in pemphigus vulgaris. | Br J Dermatol | 2026 | 41546647 | PubTator, text mining | PubMed |
| Fibroblast growth factor-inducible 14 signalling pathway in cutaneous wounds: a potential therapeutic target. | J Wound Care | 2026 | 41528787 | PubTator, text mining | PubMed |
| Cancer cachexia: molecular basis and therapeutic advances. | Signal Transduct Target Ther | 2026 | 41526343 | PubTator, text mining | PubMed |
| Inflammatory proteins mediating the effects of lipidomes on ulcerative colitis: A two-step Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41517754 | PubTator, text mining | PubMed |
| Multimodal biomarker landscape in vestibular schwannoma. | Curr Opin Neurol | 2026 | 41502327 | PubTator, text mining | PubMed |
| Comprehensive profiling of lactylation-associated genes in pulmonary hypertension through bulk and single-cell RNA sequencing integration. | Respir Res | 2026 | 41484613 | PubTator, text mining | PubMed |
| Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study. | J Autoimmun | 2026 | 41477970 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8742/papers?page=5